Dr Chun Loo Gan understands the importance of patient-centred care and is committed to providing expert personalised cancer care to his patients and their loved ones. He speaks fluent English and Mandarin, and understands a variety of Chinese dialects including Cantonese and Hokkien. Dr Gan looks forward to supporting patients in a language they are familiar with.
Dr Chun Loo Gan is an Australian trained medical oncologist at Icon Cancer Centre Chermside and Icon Cancer Centre Greenslopes. In 2011 he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at the University of Melbourne and subsequently undertook basic physician training at the Royal Melbourne Hospital. Dr Gan later commenced advanced medical oncology training at Monash Medical Centre and Olivia Newton-John Cancer Centre in Melbourne, Victoria. He undertook a 12-month clinical trial fellowship at Monash Health Translation Precinct and became a Fellow of the Royal Australasian College of Physicians in 2018.
Dr Gan is a strong advocate for research and clinical trials with a particular interest in genitourinary and gastrointestinal cancers and melanoma. In 2019 he completed a two-year genitourinary oncology fellowship at the Tom Baker Cancer Centre in Calgary, Canada, under the supervision of Prof. Daniel Heng, the founder of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). As the IMDC fellow, Dr Gan led multiple international collaborative research studies in advanced renal cell carcinoma and immunotherapy. He presented his research work at international and national meetings and received several awards including two prestigious Merit Awards from the American Society of Clinical Oncology and the Novartis Oncology Young Canadian Investigator Award. Dr Gan has also completed a Masters in Cancer Sciences at the University of Melbourne with a particular focus in cancer immunotherapy.
Dr Gan can converse in English and Mandarin, and looks forward to supporting patients in a language they are familiar with. His clinical experience covers a broad range of solid tumour malignancies with a special interest in gastrointestinal cancer, genitourinary cancer, breast cancer, lung cancer and melanoma.